Pfizer Will Unload Nutrition Division, Keep Consumer Product Unit
This article was originally published in The Tan Sheet
Executive Summary
Pfizer will divest or spin off its nutrition unit but the firm will keep its consumer product business and look into future OTC switches.
You may also be interested in...
Lipitor OTC Switch Would Force Pfizer To Clear Big Research Hurdles
Pfizer would face major hurdles in research on consumers’ safe self-selection for FDA to approve an OTC switch of the firm’s cholesterol treatment Lipitor.
Pfizer Consumer Chief Sees Chronic Conditions In OTC Future
Future OTC switches of drugs for chronic conditions like high cholesterol could "fundamentally help" alter the health care environment and lower costs, says Pfizer Consumer Healthcare President Paul Sturman.
Pfizer CEO Read Expects Gradual Plans For Change In Second Half 2011
Pfizer expects to unveil restructuring plans, including the potential divestiture of its Consumer Healthcare and Nutrition units, in the second half of 2011.